Table 1 Relation between Cyclin L1 gene expression and clinico-pathological features of tumours
From: Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma
Number of cases | Overexpression Number of cases (%) | P -value * | |
|---|---|---|---|
Localisation | |||
All | 96 | 55 (57%) | |
Hypopharynx | 64 | 38 (59%) | |
Oropharynx | 20 | 13 (65%) | 0.245 |
Oral cavity | 12 | 4 (33%) | |
Tumour size | |||
T1 | 12 | 7 (58%) | |
T2 | 49 | 33 (67%) | 0.065 |
T34 | 35 | 15 (43%) | |
Lymph node involvement | |||
N0 | 44 | 22 (50%) | 0.59 |
N+ | 52 | 33 (63%) | |
Tumour differentiation | |||
Well | 30 | 13 (43%) | 0.34 |
Moderately | 34 | 22 (65%) | |
Poorly to undifferentiated | 32 | 20 (62%) | |
